Amgen to respond to senator inquiry
- Share via
From Times Staff and Wire Reports
Amgen Inc. said it would cooperate with an inquiry from Sen. Charles E. Grassley (R-Iowa) into whether the company failed to provide the Food and Drug Administration with data from safety studies of its top-selling anemia drugs.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
